# Ibuprofen vs Expectant Management for hsPDA in Preterm Infants: Retrospective Cohort

> **NCT07533721** · — · COMPLETED · sponsor: **Shengjing Hospital** · enrollment: 541 (actual)

## Conditions studied

- Patent Ductus Arteriosus
- Infant, Premature

## Interventions

- **DRUG:** Ibuprofen

## Key facts

- **NCT ID:** NCT07533721
- **Lead sponsor:** Shengjing Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-01
- **Primary completion:** 2025-06-30
- **Final completion:** 2025-06-30
- **Target enrollment:** 541 (ACTUAL)
- **Last updated:** 2026-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07533721

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07533721, "Ibuprofen vs Expectant Management for hsPDA in Preterm Infants: Retrospective Cohort". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07533721. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*